Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2010
02/17/2010CN101649351A Methods for diagnosis and therapy of cancer and composition useful therein
02/17/2010CN101649328A Ad5 D24 conditional reproduction type adenovirus carrier for expressing multiple exogenous genes, constructing method and application thereof
02/17/2010CN101649327A Method for expressing androctonus australis hector toxin by saccharomyces cerevisiae
02/17/2010CN101649326A Gene recombination mediated by phiC312 and inheritance reformation for erythrocin producing bacterium
02/17/2010CN101649325A Gene series technology for increasing main component content of gene engineering isovaleryl selectomycin
02/17/2010CN101649324A Fungicide chlorothalonil hydrolysis dechlorination enzyme gene
02/17/2010CN101649323A Human aldehyde dehydrogenase 2 sequence designed according to preferred codon of pichia pastoris
02/17/2010CN101649322A Separation clone of rice japonica type hybrid fertility gene S5-j and application thereof
02/17/2010CN101649321A Arisaema amurense maxim agglutinin protein coding sequence and application thereof
02/17/2010CN101649320A Recombinant anthropogenic hepatocyte growth factor (HGF) activating factor and application thereof
02/17/2010CN101649319A Tumor distinctive embedment promoter, constructing method and application thereof
02/17/2010CN101649318A Pretreatment method for pathogenic bacteria gene identification in clinical samples
02/17/2010CN101649317A Method for quickly extracting and preserving silica gel membrane type DNA
02/17/2010CN101649316A Method for quickly extracting pathogen PCR nucleic acid template in foods
02/17/2010CN101649315A Efficient gene cloning method
02/17/2010CN101649307A Method and compositions for improved polynucleotide synthesis
02/17/2010CN100590201C Nucleic acid labeling method and liquid composition
02/17/2010CN100590198C Method and compositions for improved polynucleotide synthesis
02/17/2010CN100590197C Nucleic acid sequence of pavlova viridis C20 poly unsaturated fatty acid extension enzyme and its application
02/17/2010CN100590196C Branched neutral amino acid transporters acting as single molecule
02/17/2010CN100590195C Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin B12 biosynthesis
02/17/2010CN100590133C Growth hormone and serum albumni recombinant fusion protein
02/17/2010CN100590131C Methods and compounds for the targeting of protein to exosomes
02/16/2010USRE41139 Polyunsaturated fatty acids in plants
02/16/2010USRE41129 Cytokine zalpha11 ligand polynucleotides
02/16/2010US7663037 Plants and seeds of corn variety CV078495
02/16/2010US7663036 Plants and seeds of hybrid corn variety CH945822
02/16/2010US7663035 Plants and seeds of corn variety CV193192
02/16/2010US7663034 Plants and seeds of corn variety CV520536
02/16/2010US7663031 Maize variety PHW2M
02/16/2010US7663030 Inbred corn line G07-NPFA7183
02/16/2010US7663029 Soybean variety RJS38001
02/16/2010US7663028 Method of increasing seed yield and growth eIF-5A
02/16/2010US7663027 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass in plants
02/16/2010US7663026 Transformation of seaweed utilizing biolistic gene transfer to spores
02/16/2010US7663025 Transgenic plants having improved tolerance to abiotic stress such as drought, shade, cold, heat and low nitrogen conditions; member of the SCARECROW family
02/16/2010US7663024 P15 hairpin constructs and use
02/16/2010US7663023 decreasing lignin content and improving lignin profiles; exhibit improved digestibility; down-regulation of lignin biosynthesis genes; delaying flowering in an alfalfa plant; hydroxycinnamoyl transferase (HCT)
02/16/2010US7663022 genes encoding the enzyme luciferase and its corresponding substrate luciferin are incorporated into a native plant genome; phototransformation; produce light that facilitate night-time harvesting, house and landscaping plants
02/16/2010US7663021 Transgenic pineapple plants with modified carotenoid levels and methods of their production
02/16/2010US7663020 Generation of plants with altered oil content
02/16/2010US7663019 Transgenic snakes and methods of making
02/16/2010US7663018 Animal model involving transgenic manipulation of amyloid precursor protein; useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular Alzheimer's disease; drug screening
02/16/2010US7663017 animal models having disrupted genes, used to test the immunogenicity of human vaccine candidates; drug screening
02/16/2010US7662951 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
02/16/2010US7662950 siRNA targeting myeloid differentiation primary response gene (88) (MYD88)
02/16/2010US7662949 Immunostimulatory oligoribonucleotides
02/16/2010US7662948 Antisense oligonucleotides against VR1
02/16/2010US7662947 Arabidopsis-stomatal-specific promoter and a genetic construct containing the promoter for expression of nucleic acids in plants
02/16/2010US7662946 Sequences encoding ADAMTS13 genes and proteins
02/16/2010US7662945 Expression vector comprising nucleotide sequences coding C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of vision defcets associated with cell proliferative disorders
02/16/2010US7662943 Promoter sequences for use as regulatory tool in vector/plasmid mediatged transformation
02/16/2010US7662941 Embryonic stem cell self maintenance and renewal reporter
02/16/2010US7662939 Molecular determinants of tropism and virulence in enteroviruses
02/16/2010US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability
02/16/2010US7662923 Modified vitamin K-dependent polypeptides
02/16/2010US7662916 Modified HIV Env polypeptides
02/16/2010US7662796 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
02/16/2010US7662795 Enhancement of adenoviral oncolytic activity by modification of the E1A gene product
02/16/2010US7662794 DNA enzyme to inhibit plasminogen activator inhibitor-1
02/16/2010US7662793 Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter
02/16/2010US7662792 Modulation of Fas and FasL expression
02/16/2010US7662791 Suppression gene expression
02/16/2010US7662782 Melanocortin 1 receptor selective compounds
02/16/2010US7662775 Method for screening agents for the treatment of diabetes
02/16/2010US7662772 Methods for treating congestive heart failure
02/16/2010US7662769 Acetylglucosaminyl transferases; neovascularization inhibitor screening; antibodies; kits
02/16/2010US7662642 Method for detection of specific antibodies using ubiquitin fusion proteins
02/16/2010US7662633 Method of screening for inhibitors of osteopontin
02/16/2010US7662629 Cationic peptide scaffold conjugated to a nuclear targeting peptide through a specified hydrolysis resistant chemical linkage; use in transfection i.e. nonviral gene transfer
02/16/2010US7662628 Method for producing a protein by culturing in culture medium a host cell transfected with a vector comprising a nucleic acid having the given nucleotide sequence; treatment of myocardial necrosis or ischemia reperfusion injuries; gene therapy; inhibits cell death associated with hypoxia, apoptosis
02/16/2010US7662627 Adeno-associated virus materials and methods
02/16/2010US7662624 Metal-binding therapeutic peptides
02/16/2010US7662623 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
02/16/2010US7662622 Flea peritrophin nucleic acid molecules
02/16/2010US7662621 a part of the interior gene is deleted, and the transgene is inserted into the gap created by the deletion; capable of expressing a desired protein in target cells.
02/16/2010US7662620 Stem cell-derived neuron survival factor polypeptides (SDNSF) for use in prevention and treatment of cell proliferative, neurodegenerative and cardiovascular disorders
02/16/2010US7662619 Addition of histidine amino acids to the cytoplasmic domains of membrane and viral envelope proteins for the purpose of solubilizing, and/or reconstituting viral envelope proteins in lipid containing vesicles
02/16/2010US7662609 E.coli host cells with modified PhoS/PstS periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs
02/16/2010US7662608 Transgenic cell line modified to procontinuously produce budding particle for use as model in diagnostic screening and testing; drug monitoring; antitumor agents; viricides
02/16/2010US7662605 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
02/16/2010US7662603 serine hydroxymethyltransferase as novel target for herbicides
02/16/2010US7662601 thymine-DNA glycosylase (TDG) which releases thymine bases from single stranded (ss) DNA and double stranded (ds) DNA, said TDG obtainable by modification of a uracil-DNA glycosylase (UDG), wherein said modification consists of replacing tyrosine at amino acid position 147 with a different amino acids
02/16/2010US7662600 Modified flavin adenine dinucleotide dependent glucose dehydrogenase
02/16/2010US7662599 Polyketide synthetase activity; vectors; host cells
02/16/2010US7662597 PUFA polyketide synthase systems and uses thereof
02/16/2010US7662591 Nucleic acid sequences having gene transcription regulatory qualities
02/16/2010US7662590 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing
02/16/2010US7662589 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing
02/16/2010US7662587 Recombinant Escherichia host cell, comprising chimeric genetic construct, knockout mutation in gene gcvA (encoding the glycine cleavage enzyme), and knockout mutation in gene spr (encoding suppressor of prc); fusion proteins
02/16/2010US7662586 host cells; tumor antigens; for treatment, prevention of cancer
02/16/2010US7662585 ErbB4 receptor-specific neuregulin related ligands and uses therefor
02/16/2010US7662584 Inducing an elevated unfolded protein response by using an isolated heterologous nucleic acid endocing a HAC1 protein, a PTC2 protein or an 1re1 protein; secreted therapeutic or an industrial enzyme
02/16/2010US7662583 Nutrient medium free of exogenous supply of UDP-glucose; quercetin glycosylation
02/16/2010US7662568 Used in highly specific and sensitive nucleic acid amplification assays; ability to detect biological toxins at sub-attomolar (10-18M) concentrations
02/16/2010US7662565 Approaches to identify less harmful tobacco and tobacco products
02/16/2010US7662560 Broad specificity affinity arrays: a qualitative approach to complex sample discrimination
02/16/2010US7662557 Methods for producing members of specific binding pairs
02/16/2010US7662556 Isolating and cloning full-lengh gene sequences using capped messenger RNA
02/16/2010US7662553 Polymorphisms in the ERCC1 gene for predicting treatment outcome